Jerusalem’s Oramed Pharmaceuticals is one step closer to putting a groundbreaking oral insulin capsule on the market for people with Type 2 diabetes. The company is about to begin Phase 2 clinical trials on 147 people at about a dozen medical centers in the United States. CEO Nadav Kidron tells ISRAEL21c that the company’s flagship product could revolutionize the treatment … [Read more...]
| CLICK HERE To Receive FREE AIMA News and Updates |
|
Israel Is At War and We Need Your Help! Medical Equipment and Suppies Are Desperately Needed. Email info@aima4u.com To Learn What YOU Can Do.
Upcoming Events
